O’Reilly brings a background spanning over 13 years at Humana, where he oversaw enterprise compliance for Medicare Advantage, Medicaid, and value-based primary care operations. His expertise in navigating complex regulatory environments is expected to guide DarioHealth as the company scales its AI-driven behavioral health and chronic condition management platforms.

CEO Erez Raphael noted that O’Reilly’s experience with M&A and clinical operations will be instrumental as the firm moves closer to care through its channel partner strategy. For his part, O’Reilly emphasized that the company’s focus on measurable outcomes and digital engagement aligns with the shifting demands of health plans and providers seeking scalable, compliant solutions.